<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-2127</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЙ СЛУЧАЙ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASE</subject></subj-group></article-categories><title-group><article-title>Успешное применение продолжительной гемофильтрации при контраст-индуцированной нефропатии</article-title><trans-title-group xml:lang="en"><trans-title>Effective long-term hemofiltration in contrast-induced nephropathy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Табакьян</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tabakyan</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>н.с. отдела возрастных проблем сердечно-сосудистых заболеваний</p></bio><email xlink:type="simple">tabakyan@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акчурин</surname><given-names>Р. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Akchurin</surname><given-names>R. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>руководитель отдела сердечно-сосудистой хирургии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Заруба</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaruba</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>в.н.с. отдела возрастных проблем сердечно-сосудистых заболеваний</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Власова</surname><given-names>Э. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Vlasova</surname><given-names>E. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>с.н.с. отдела сердечно-сосудистой хирургии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт клинической кардиологии им. А.Л. Мясникова ФГУ Российского кардиологического научно-производственного комплекса Росмедтехнологии. Москва</institution></aff><aff xml:lang="en"><institution>A.L. Myasnikov Research Institute of Clinical Cardiology, Russian Cardiology Scientific and Clinical Complex. Moscow</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>20</day><month>10</month><year>2010</year></pub-date><volume>9</volume><issue>5</issue><fpage>80</fpage><lpage>85</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Табакьян Е.А., Акчурин Р.С., Заруба А.Ю., Власова Э.Е., 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="ru">Табакьян Е.А., Акчурин Р.С., Заруба А.Ю., Власова Э.Е.</copyright-holder><copyright-holder xml:lang="en">Tabakyan E.A., Akchurin R.S., Zaruba A.Y., Vlasova E.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/2127">https://cardiovascular.elpub.ru/jour/article/view/2127</self-uri><abstract><p>Цель. Проанализировать причины развития контраст-индуцированной нефропатии (КИН) после коронарной ангиопластики (КАП) и возможности применения продолжительной гемофильтрации для лечения КИН. Материал и методы. Риск развития КИН оценивали по сумме баллов согласно рекомендациям Barrett ВJ, Parfrey PS, 2006. Коронароангиографию(КАГ) со стентированием: выполняли трансфеморальным доступом, использовали низкоосмолярный контраст ультравист 370. Процедуры гемофильтрации проводили на аппарате Diapact®CRRT. Объем замещения &gt; 30 мл/кг/час, использовали раствор Duosol® на основе бикарбонатного буфера. Антикоагуляция гепарином в дозе 10 ед/кг/ч под контролем активированного времени свертывания. Контроль гематокрита, содержания калия и натрия, глюкозы, рН, бикарбоната, лактата в венозной крови, каждые 2-3 ч в процессе процедуры. Результаты. У мужчины 71 года с ишемической болезнью сердца (ИБС), постинфарктным кардиосклерозом показанием к проведению КАГ послужила: выявленная ишемия, угроза развития повторного инфаркта миокарда (ИМ). В анамнезе сахарный диабет на терапии новонормом, метформином. Креатинин (Кр) сыворотки 109 мкмоль/л, скорость клубочковой фильтрации (CКФ) 50,5 мл/мин/1,73м2 , риск развития КИН умеренный. Выполнена баллонная дилатация огибающей артерии и артерии тупого края (АТК), стентирование АТК, дилатация и стентирование диагональной артерии. Введено 400мл контрастного вещества: Через 24 ч после вмешательства повышение уровня Кр &gt; 25 % от исходного, гидратация физиологическим раствором хлорида натрия без эффекта, через 48 ч рост уровня Кр, CКФ &lt; 15 мл/ мин/1,73м2 , олигурия. С помощью продолжительной гемофильтрации удалось добиться обратного развития КИН. Заключение. Продолжительная гемофильтрация может сыграть решающую роль в лечении КИН в случае развития тяжелого ацидоза, олигурии, снижения СКФ &lt;15 мл/мин/1,73 м2 . До проведения вмешательства с использованием контрастного вещества следует предпринять все возможные профилактические меры, чтобы не допустить развития КИН.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To analyse the causes of contrast-induced nephropathy (CIN) after coronary angioplasty (CAP), as well as the potential of long-term hemofiltration in CIN treatment. Material and methods. CIN risk was assessed by total score, as recommended by Barrett ВJ and Parfrey PS (2006). CAP with stent implantation was performed via femoral access, with hypoosmolar contrast ultravist 370. Hemofiltration was performed with the Diapact®CRRT device (substitution volume &gt;30 ml/kg/h; Duosol® solution in bicarbonate buffer; heparin anticoagulation (10 U/kg/h) under activated clotting time control). Venous levels of hematocrit, K, Na, glucose, pH, bicarbonate, and lactate were controlled every 2-3 hours. Results. In a 71-year-old male patient with coronary heart disease (CHD) and post-infarction cardiosclerosis, the indications for CAP included myocardial ischemia and recurrent myocardial infarction (MI) risk. Concomitant diabetes mellitus was treated with novonorm and metformin. At baseline, serum creatinine level was 109 mkmol/l and glomerular filtration rate (GFR) — 50,5 ml/min/1,73 m2 , with moderate CIN risk. Balloon dilatation of circumference artery and blunt edge artery (BEA), obtuse marginal artery (OMA) stenting, OMA dilatation and stenting were performed. In total, 400 ml of contrast were used. Twenty-four hours later, creatinine level increase by 25 % was observed, with no effect from saline hydration. After 48 h, further increase in creatinine concentration, GFR &lt;15 ml/min/1,73 m2 , and oligouria were observed. Long-term hemofiltration resulted in CIN regression. Conclusion. Long-term hemofiltration could have a crucial role in CIN treatment, in case of severe acidosis, oligouria, and GFR reduction &lt;15 ml/min/1,73 m2 . Before the contrast administration, all necessary measures should be taken, to prevent CIN development.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>продолжительная гемофильтрация</kwd><kwd>контраст-индуцированная нефропатия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>long-term hemofiltration</kwd><kwd>contrast-induced nephropathy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Toprak O, Cirit M. Risk Factors for Contrast-Induced Nephropathy. Kidney Blood Press Res 2006; 29: 84-93.</mixed-citation><mixed-citation xml:lang="en">Toprak O, Cirit M. Risk Factors for Contrast-Induced Nephropathy. Kidney Blood Press Res 2006; 29: 84-93.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Morcos SK, Thomsen HS. European Society of Urogenital Radiology: European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 2003; 28: 187- 90.</mixed-citation><mixed-citation xml:lang="en">Morcos SK, Thomsen HS. European Society of Urogenital Radiology: European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 2003; 28: 187- 90.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cronin RE. Contrast-induced nephropathy: pathogenesis and prevention. Pediatr Nephrol. Published online 15 May 2009.</mixed-citation><mixed-citation xml:lang="en">Cronin RE. Contrast-induced nephropathy: pathogenesis and prevention. Pediatr Nephrol. Published online 15 May 2009.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cheung CM, Ponnusamy A, Anderton JG. Management of acute renal failure in the elderly patient: a clinician’s guide. Drugs Aging 2008; 25(6): 455-76. Review.</mixed-citation><mixed-citation xml:lang="en">Cheung CM, Ponnusamy A, Anderton JG. Management of acute renal failure in the elderly patient: a clinician’s guide. Drugs Aging 2008; 25(6): 455-76. Review.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kohli A. Contrast Induced Nephropathy (CIN): Can we minimize its effects? Ind J Radiol Imag 2005; 15(3): 307-8.</mixed-citation><mixed-citation xml:lang="en">Kohli A. Contrast Induced Nephropathy (CIN): Can we minimize its effects? Ind J Radiol Imag 2005; 15(3): 307-8.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005; 68: 1422.</mixed-citation><mixed-citation xml:lang="en">Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005; 68: 1422.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mccullogh PA, Wolyn R, Racher LL, et al. Acute Renal Failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med 1997; 103: 368-75.</mixed-citation><mixed-citation xml:lang="en">Mccullogh PA, Wolyn R, Racher LL, et al. Acute Renal Failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med 1997; 103: 368-75.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol 2004; 183: 1673-89.</mixed-citation><mixed-citation xml:lang="en">Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol 2004; 183: 1673-89.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Toprak O, Cirit M, Bayata S, et al. Review of the radiocontrast nephropathy risk profiles and risk stratification. Anadolu Kardiyol Derg 2004; 4: 331-5.</mixed-citation><mixed-citation xml:lang="en">Toprak O, Cirit M, Bayata S, et al. Review of the radiocontrast nephropathy risk profiles and risk stratification. Anadolu Kardiyol Derg 2004; 4: 331-5.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous cor-onary intervention: development and initial validation. JACC 2004; 44: 1393-9.</mixed-citation><mixed-citation xml:lang="en">Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous cor-onary intervention: development and initial validation. JACC 2004; 44: 1393-9.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93: 1515-9.</mixed-citation><mixed-citation xml:lang="en">Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004; 93: 1515-9.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Barrett BJ, Parfrey PS. Preventing Nephropathy Induced by Contrast Medium. N Engl J Med 2006; 354: 379-86.</mixed-citation><mixed-citation xml:lang="en">Barrett BJ, Parfrey PS. Preventing Nephropathy Induced by Contrast Medium. N Engl J Med 2006; 354: 379-86.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wong GTC, Irwin MG. Contrast-induced nephropathy. British J of Anaesthesia 2007; 99(4): 474-83.</mixed-citation><mixed-citation xml:lang="en">Wong GTC, Irwin MG. Contrast-induced nephropathy. British J of Anaesthesia 2007; 99(4): 474-83.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Cullough PAMc. Contrast- Induced Acute Kidney Injury. JACC 2008; 51: 1419-28.</mixed-citation><mixed-citation xml:lang="en">Cullough PAMc. Contrast- Induced Acute Kidney Injury. JACC 2008; 51: 1419-28.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/ non-ST-elevation myocardial infarction – executive summary: a report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/NonnST-Elevation Myocardial Infarction). JACC 2007; 50: 652-726.</mixed-citation><mixed-citation xml:lang="en">Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/ non-ST-elevation myocardial infarction – executive summary: a report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/NonnST-Elevation Myocardial Infarction). JACC 2007; 50: 652-726.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lin J, Bonventre JV. Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens 2005; 14: 105-10.</mixed-citation><mixed-citation xml:lang="en">Lin J, Bonventre JV. Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens 2005; 14: 105-10.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrastinduced nephropathy with sodium bicarbonate: a randomized con-trolled trial. JAMA 2004; 291: 2328-34.</mixed-citation><mixed-citation xml:lang="en">Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrastinduced nephropathy with sodium bicarbonate: a randomized con-trolled trial. JAMA 2004; 291: 2328-34.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Pakfetrat M, Nikoo MH, Malehmakan L, et al. A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrastinduced nephrop-athy: a randomized, double-blind trial. Int Urol Nephrol 2009 in press.</mixed-citation><mixed-citation xml:lang="en">Pakfetrat M, Nikoo MH, Malehmakan L, et al. A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrastinduced nephrop-athy: a randomized, double-blind trial. Int Urol Nephrol 2009 in press.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Solomon R. REMEDIAL: a role for sodium bicarbonate in the prevention of contrast-induced nephropathy. Nat Clin Pract Cardiovasc Med 2007; 4: 474-5.</mixed-citation><mixed-citation xml:lang="en">Solomon R. REMEDIAL: a role for sodium bicarbonate in the prevention of contrast-induced nephropathy. Nat Clin Pract Cardiovasc Med 2007; 4: 474-5.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Navaneethan SD, Sonal Singh, Suresh Appasamy, et al. Sodium Bicarbonate therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. Am J Kidney Diseases 2009; l53: 617-27.</mixed-citation><mixed-citation xml:lang="en">Navaneethan SD, Sonal Singh, Suresh Appasamy, et al. Sodium Bicarbonate therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. Am J Kidney Diseases 2009; l53: 617-27.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Frank H, Werner D, Lorusso V, et al. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrastinduced nephropathy in chronic renal failure. Clin Nephrol 2003; 60: 176-82.</mixed-citation><mixed-citation xml:lang="en">Frank H, Werner D, Lorusso V, et al. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrastinduced nephropathy in chronic renal failure. Clin Nephrol 2003; 60: 176-82.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333-40.</mixed-citation><mixed-citation xml:lang="en">Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333-40.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Vogt B, Ferrari P, Schönholzer C, et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111: 692-8.</mixed-citation><mixed-citation xml:lang="en">Vogt B, Ferrari P, Schönholzer C, et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111: 692-8.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lee PT, Chou KJ, Liu CP, et al. Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. JACC 2007; 50: 1015-20.</mixed-citation><mixed-citation xml:lang="en">Lee PT, Chou KJ, Liu CP, et al. Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. JACC 2007; 50: 1015-20.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Cruz DN, Perazella MA, Bellomo R, et al. Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Kidney Dis 2006; 48(3): 361-71.</mixed-citation><mixed-citation xml:lang="en">Cruz DN, Perazella MA, Bellomo R, et al. Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review. Am J Kidney Dis 2006; 48(3): 361-71.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast- agent-induced nephropathy by hemofltration. N Engl J Med 2003; 349: 1333-40.</mixed-citation><mixed-citation xml:lang="en">Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast- agent-induced nephropathy by hemofltration. N Engl J Med 2003; 349: 1333-40.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Marenzi G, Lauri G, Campodonico J, et al. Comparison of two hemofltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 2006; 119: 155- 62.</mixed-citation><mixed-citation xml:lang="en">Marenzi G, Lauri G, Campodonico J, et al. Comparison of two hemofltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 2006; 119: 155- 62.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Po-Tsang Lee, Kang-Ju Chou, Chun-Peng Liu, et al. Renal Protection for Coronary Angiography in Advanced Renal Failure Patients by Prophylactic Hemodialysis: A Randomized Controlled Trial. JACC 2007; 50: 1015-20.</mixed-citation><mixed-citation xml:lang="en">Po-Tsang Lee, Kang-Ju Chou, Chun-Peng Liu, et al. Renal Protection for Coronary Angiography in Advanced Renal Failure Patients by Prophylactic Hemodialysis: A Randomized Controlled Trial. JACC 2007; 50: 1015-20.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Martin Tepel. Does prophylactic haemodialysis protect kidney function after angiography? Nephrol Dial Transplant 2008; 23: 1473-5.</mixed-citation><mixed-citation xml:lang="en">Martin Tepel. Does prophylactic haemodialysis protect kidney function after angiography? Nephrol Dial Transplant 2008; 23: 1473-5.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
